Our Company Strategy & Mission Leadership Our Board Partnering Opportunities Out-Licensing Opportunities Contact Our Pipeline Clinical Trials Clinical Trials Compassionate Use Disease Information Innovation Engine Akeso Partnership Overview Ivonescimab (SMT112) Overview Therapeutic Areas News Center Media Resources Press Releases Investor Center Investor Center Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Career Opportunities
Sub-MIC Effect Of SMT19969 Vs. Comparators On Clostridium Difficile Toxin A And B Concentrations And Cell Cytotoxicity Sub-MIC Effect Of SMT19969 Vs. Comparators On Clostridium Difficile Toxin A And B Concentrations And Cell Cytotoxicity October 10, 2014 By CKD Digital
Sub-MIC Effect Of SMT19969 Vs. Comparators On Clostridium Difficile Toxin A And B Concentrations And Cell Cytotoxicity
Sub-MIC Effect Of SMT19969 Vs. Comparators On Clostridium Difficile Toxin A And B Concentrations And Cell Cytotoxicity October 10, 2014 By CKD Digital
Website Cookies This website uses cookies: Please see our Privacy Policy to understand how we use cookies. Okay, thanks